These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6495325)

  • 21. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
    Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
    J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioassayable growth hormone activity in blood from healthy individuals and acromegalic patients.
    Thorngren KG; Hallengren B
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):3-9. PubMed ID: 3946103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galanin decreases circulating growth hormone levels in acromegaly.
    Giustina A; Bodini C; Doga M; Schettino M; Pizzocolo G; Giustina G
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1296-300. PubMed ID: 1375598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
    Arosio M; Ambrosi B; Guglielmino L; Faglia G
    J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional supervoltage irradiation is an effective treatment for acromegaly.
    Eastman RC; Gorden P; Roth J
    J Clin Endocrinol Metab; 1979 Jun; 48(6):931-40. PubMed ID: 447799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
    Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acromegaly by transsphenoidal microsurgery.
    Giovanelli MA; Motti ED; Paracchi A; Beck-Peccoz P; Ambrosi B; Faglia G
    J Neurosurg; 1976 Jun; 44(6):677-86. PubMed ID: 818343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
    Nyquist P; Laws ER; Elliott E
    Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
    Hattori N; Shimatsu A; Kato Y; Koshiyama H; Ishikawa Y; Assadian H; Tanoh T; Nagao M; Imura H
    J Clin Endocrinol Metab; 1990 Mar; 70(3):771-6. PubMed ID: 2106529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GHRF test in acromegalic patients for the evaluation of therapeutic results.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1985 Nov; 147(3):273-80. PubMed ID: 3937295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
    Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical results and clinical analysis of 19 cases of acromegaly].
    Sugimoto S; Abe H; Kaneko S; Tokuda K; Aida T; Tsuru M; Nakagawa K; Akikawa K; Matsubara M
    Hokkaido Igaku Zasshi; 1985 Mar; 60(2):241-51. PubMed ID: 3997057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transsphenoidal subtotal hypophysectomy in the treatment of acromegaly.
    Bohmer T; Berdal P; Haugen HN
    Acta Endocrinol (Copenh); 1974 Nov; 77(3):477-84. PubMed ID: 4479318
    [No Abstract]   [Full Text] [Related]  

  • 39. Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.
    Arihara Z; Sakurai K; Yamada S; Murakami O; Takahashi K
    Tohoku J Exp Med; 2008 Dec; 216(4):325-9. PubMed ID: 19060447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL; Wersäll J; Werner S
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.